RU94045151A - Биоразлагаемые полимеры и способ их получения - Google Patents

Биоразлагаемые полимеры и способ их получения

Info

Publication number
RU94045151A
RU94045151A RU94045151/04A RU94045151A RU94045151A RU 94045151 A RU94045151 A RU 94045151A RU 94045151/04 A RU94045151/04 A RU 94045151/04A RU 94045151 A RU94045151 A RU 94045151A RU 94045151 A RU94045151 A RU 94045151A
Authority
RU
Russia
Prior art keywords
biogradable
lypophilic
fragments
group attached
organic group
Prior art date
Application number
RU94045151/04A
Other languages
English (en)
Other versions
RU2114865C1 (ru
Inventor
Клавенесс Йо
No]
Редфорд Кейт
Солберг Ян
Gb]
Странде Пер
Original Assignee
Нюкомед Имагинг АС. (NO)
Нюкомед Имагинг АС.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Нюкомед Имагинг АС. (NO), Нюкомед Имагинг АС. filed Critical Нюкомед Имагинг АС. (NO)
Publication of RU94045151A publication Critical patent/RU94045151A/ru
Application granted granted Critical
Publication of RU2114865C1 publication Critical patent/RU2114865C1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1857—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. PLGA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Acoustics & Sound (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Polyamides (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Несшитые неполипептидные полимеры, содержащие биоразлагаемые липофильные боковые цепи, содержащие метиленовые диэфирные фрагменты формулы, приведенной в описании. Липофильные фрагменты являются биоразлагаемо отщепляемыми с образованием растворимого в воде полимера.

Claims (1)

  1. Несшитые неполипептидные полимеры, содержащие биоразлагаемые липофильные боковые цепи, содержащие метиленовые диэфирные фрагменты формулы, приведенной в описании. Липофильные фрагменты являются биоразлагаемо отщепляемыми с образованием растворимого в воде полимера.
RU94045151A 1992-03-06 1993-03-05 Биоразлагаемые несшитые полимеры RU2114865C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9204918.8 1992-03-06
GB929204918A GB9204918D0 (en) 1992-03-06 1992-03-06 Chemical compounds

Publications (2)

Publication Number Publication Date
RU94045151A true RU94045151A (ru) 1996-09-27
RU2114865C1 RU2114865C1 (ru) 1998-07-10

Family

ID=10711636

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94045151A RU2114865C1 (ru) 1992-03-06 1993-03-05 Биоразлагаемые несшитые полимеры

Country Status (30)

Country Link
US (1) US5574097A (ru)
EP (1) EP0629214B1 (ru)
JP (1) JP3281381B2 (ru)
CN (1) CN1038940C (ru)
AT (1) ATE144540T1 (ru)
AU (1) AU670069B2 (ru)
BG (1) BG99070A (ru)
BR (1) BR9306043A (ru)
CA (1) CA2130671A1 (ru)
CZ (1) CZ281738B6 (ru)
DE (1) DE69305628T2 (ru)
DK (1) DK0629214T3 (ru)
ES (1) ES2093413T3 (ru)
FI (1) FI944078A (ru)
GB (1) GB9204918D0 (ru)
GR (1) GR3022075T3 (ru)
HU (1) HUT69070A (ru)
IL (1) IL104962A (ru)
LT (2) LT3216B (ru)
LV (1) LV10294B (ru)
MD (2) MD940199A (ru)
NO (1) NO303123B1 (ru)
NZ (1) NZ249547A (ru)
OA (1) OA10097A (ru)
PH (1) PH30746A (ru)
PL (1) PL174125B1 (ru)
RU (1) RU2114865C1 (ru)
SK (1) SK105694A3 (ru)
WO (1) WO1993018070A1 (ru)
ZA (2) ZA931599B (ru)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9318288D0 (en) * 1993-09-03 1993-10-20 Nycomed Imaging As Improvements in or relating to contrast agents
GB9417941D0 (en) * 1994-09-06 1994-10-26 Nycomed Imaging As Improvements in or relating to contrast agents
CA2164237A1 (en) * 1994-12-08 1996-06-09 Takeharu Tabuchi Acrylic monomer
US6309999B1 (en) * 1999-03-19 2001-10-30 Chandra P. Sharma Process for the preparation of an immunoadsorbent matrix
US6720445B2 (en) * 2000-12-21 2004-04-13 Beacon Laboratories, Inc. Acetyloxymethyl esters and methods for using the same
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
ES2380287T3 (es) 2001-06-11 2012-05-10 Xenoport, Inc. Profármacos de análogos de GABA, composiciones y sus usos
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
AUPR951501A0 (en) * 2001-12-14 2002-01-24 Smart Drug Systems Inc Modified sustained release pharmaceutical system
CA2484761C (en) 2002-05-24 2010-11-09 Angiotech International Ag Compositions and methods for coating medical implants
US8313760B2 (en) 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
US20030235610A1 (en) * 2002-06-21 2003-12-25 Piedmont Pharmaceuticals, Llc Liposomes containing biologically active compounds
US20050152941A1 (en) * 2003-11-20 2005-07-14 Angiotech International Ag Soft tissue implants and anti-scarring agents
AU2005301970B2 (en) 2004-11-04 2011-06-02 Arbor Pharmaceuticals, Llc Gabapentin prodrug sustained release oral dosage forms
AU2005100176A4 (en) * 2005-03-01 2005-04-07 Gym Tv Pty Ltd Garbage bin clip
US8999323B2 (en) 2007-11-23 2015-04-07 Technische Universität Wien Composition that can be cured by polymerisation for the production of biodegradable, biocompatible, cross-linkable polymers on the basis of polyvinyl alcohol
JP5770272B2 (ja) * 2010-06-17 2015-08-26 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ サッカリド側基を有するポリマーとその利用
RU2543895C2 (ru) * 2013-05-17 2015-03-10 Общество С Ограниченной Ответственностью "Научно-Производственный Центр "Амфион" Гидрогелевый материал на основе сшиваемого поливинилового спирта
JP7115914B2 (ja) 2017-06-23 2022-08-09 住友化学株式会社 レジスト組成物及びレジストパターンの製造方法
GB201810788D0 (en) * 2018-06-29 2018-08-15 Biocompatibles Uk Ltd Biodegradable polymer
RU2687231C1 (ru) * 2018-08-03 2019-05-08 Сергей Борисович Врублевский Способ получения пигментов
CN109928879A (zh) * 2019-03-05 2019-06-25 贵州大学 一种丙烯酸酯碳酸酯及其均聚物和共聚物材料
CN111892707B (zh) * 2020-06-18 2021-08-13 中山大学 一种阳离子聚酰胺材料及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180646A (en) 1975-01-28 1979-12-25 Alza Corporation Novel orthoester polymers and orthocarbonate polymers
US4356166A (en) * 1978-12-08 1982-10-26 University Of Utah Time-release chemical delivery system
US4276885A (en) 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4718433A (en) 1983-01-27 1988-01-12 Feinstein Steven B Contrast agents for ultrasonic imaging
AU2698684A (en) * 1983-07-01 1985-02-07 Battelle Memorial Institute Polypeptide biodegradable et son utilisation pour le relargage progressif de medicaments
US4741956A (en) * 1986-07-09 1988-05-03 Exxon Research And Engineering Company Biodegradable coatings of ionomer polymer
AU635200B2 (en) 1988-02-05 1993-03-18 Schering Aktiengesellschaft Berlin Und Bergkamen Ultrasonic contrast agents, process for producing them and their use as diagnostic and therapeutic agents
GB9003821D0 (en) 1990-02-20 1990-04-18 Danbiosyst Uk Diagnostic aid
US5137928A (en) 1990-04-26 1992-08-11 Hoechst Aktiengesellschaft Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
AU636481B2 (en) 1990-05-18 1993-04-29 Bracco International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
PH31064A (en) 1990-09-07 1998-02-05 Nycomed As Of Nycoveten Polymers containing diester units.

Also Published As

Publication number Publication date
BR9306043A (pt) 1997-11-18
MD940199A (ru) 1996-01-31
CN1038940C (zh) 1998-07-01
WO1993018070A1 (en) 1993-09-16
DK0629214T3 (da) 1996-11-18
DE69305628T2 (de) 1997-03-06
US5574097A (en) 1996-11-12
LTIP391A (en) 1994-09-25
HUT69070A (en) 1995-08-28
ES2093413T3 (es) 1996-12-16
NO943273L (no) 1994-09-05
JPH07505177A (ja) 1995-06-08
GB9204918D0 (en) 1992-04-22
ATE144540T1 (de) 1996-11-15
SK105694A3 (en) 1995-04-12
ZA931599B (en) 1993-12-28
LV10294B (en) 1995-12-20
PH30746A (en) 1997-10-17
RU2114865C1 (ru) 1998-07-10
PL174125B1 (pl) 1998-06-30
DE69305628D1 (de) 1996-11-28
JP3281381B2 (ja) 2002-05-13
AU3642393A (en) 1993-10-05
NO303123B1 (no) 1998-06-02
FI944078A0 (fi) 1994-09-05
AU670069B2 (en) 1996-07-04
LT3216B (en) 1995-04-25
BG99070A (bg) 1995-08-28
ZA931594B (en) 1993-09-27
EP0629214B1 (en) 1996-10-23
HU9402563D0 (en) 1994-11-28
NO943273D0 (no) 1994-09-05
EP0629214A1 (en) 1994-12-21
CZ281738B6 (cs) 1997-01-15
GR3022075T3 (en) 1997-03-31
LTIP388A (en) 1994-09-25
CN1084524A (zh) 1994-03-30
CZ215294A3 (en) 1995-08-16
IL104962A (en) 1996-01-31
LT3199B (en) 1995-03-27
CA2130671A1 (en) 1993-09-07
LV10294A (lv) 1994-10-20
MD940206A (ru) 1996-01-31
FI944078A (fi) 1994-09-05
IL104962A0 (en) 1993-07-08
NZ249547A (en) 1996-08-27
OA10097A (en) 1996-12-18

Similar Documents

Publication Publication Date Title
RU94045151A (ru) Биоразлагаемые полимеры и способ их получения
DE60023138D1 (de) Verwendung eines biologisch abbaubaren Polymers
ATE39935T1 (de) Copolymer und verfahren zu seiner herstellung.
NO304432B1 (no) Biodegraderbare polymerer, fremstilling og anvendelse av slike
NZ591803A (en) Oral and personal care compositions and methods
IL115138A (en) Implantable polymer-containing molded articles for the administration of active substances to plants and processes for the preparation thereof
GB9916279D0 (en) Cellulose derivatives
DE50006412D1 (de) Haarkosmetische zubereitungen
ES555275A1 (es) Procedimiento para la obtencion de preparaciones facilmente solubles de polimeros cationicos.
ATE230613T1 (de) Polymere platinverbindungen
TR199802665T2 (xx) Piperidin asetik asit t�revleri ve bunlar�n trombotik hastal�klar�n tedavisinde kullan�m�.
ATE235909T1 (de) Biologisch kompatible und biologisch abbaubare zubereitungen enthaltend hyaluronsäure und deren derivate zur behandlung von geschwüren im verdauungsapparat
JPS56147704A (en) Dermatological composition
ES2173250T3 (es) Procedimiento para preparar xantenos polialquilados.
DE69919386D1 (de) Zusammensetzung zur behandlung von entzündungen
RO83934B1 (ro) Unguent hidrofil pe baza de colagen pentru tratamentul ragadelor mamelonare
TH4688EX (th) อนุพันธุ์ของเตตราไฮโดรแนพธาลีน
TH4688A (th) อนุพันธุ์ของเตตราไฮโดรแนพธาลีน
RO97992B1 (ro) Compozitie medicamentoasa cu actiune antiinflamatoare si procedeu de obtinere